Treatment with Cellgevity® improves glycemic index and prevents atherogenic dyslipidemia in Type 2 Diabetic rat model. JHS. 2025;3(1):24-31. Accessed May 12, 2026. https://lasujournals.ng/index.php/jhs/article/view/75